Clinical trial

Combination of Metformin With Gefitinib to Treat NSCLC

NCT01864681

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-05-01

PhasePHASE2

Study timeline

Study start (actual)2013-05-01Date precision: month

Registry last updated2018-06-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

NSCLCunresolved

EGFR Gene Amplificationunresolved

Advanced Cancerunresolved

Stage IIIB NSCLCunresolved

Stage IV NSCLCunresolved

Interventions

Gefitinib and MetforminDRUG

Gefitinib and placeboDRUG

Sponsors & collaborators

Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universitylead sponsor

Mapped research locations

ChongqingChongqing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01864681 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.